Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation

doi:10.1136/bmj-2024-079183

. 2024 Nov 19:387:e079183.

doi: 10.1136/bmj-2024-079183.

Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation

Elie A Akl^{1

2}, Joanne Khabsa³, Claire Iannizzi⁴, Vanessa Piechotta⁵, Lara A Kahale⁶, James M Barker⁷, Joanne E McKenzie⁸, Matthew J Page⁸, Nicole Skoetz⁴; PRISMA-LSR Group

Collaborators, Affiliations

Collaborators

PRISMA-LSR Group:
Tony Aburrow, Sabina Alam, Lisa Askie, Vivienne C Bachelet, Asma Ben Brahem, Lex Bouter, Isabelle Boutron, Romina Brignardello-Petersen, Jacob Burns, Anna Chaimani, Christine Chang, Stephanie Chang, Mike Clarke, Tammy Clifford, Kerry Dwan, Julian Elliott, Robin Featherstone, Markus Follmann, Christian Gluud, Gordon Guyatt, Lotty Hooft, Anna Jacobs, Svenja Krebs, Tamara Kredo, Toby Lasserson, Elizabeth Loder, Helen Macdonald, Iain Marshall, Steve McDonald, Matthew Df McInnes, Joerg Meerpohl, Maria-Inti Metzendorf, David Moher, Lorenzo Moja, Karel Gm Moons, Mohammad Hassan Murad, Reem Mustafa, Stefano Negrini, Robby Nieuwlaat, Adriani Nikolakopoulou, Monika Nothacker, Rose O'Dea, Amir Qaseem, Gabriel Rada, Melissa L Rethlefsen, Ludovic Reveiz, Maria Ximena Rojas-Reyes, Jean-Paul Salameh, Georgia Salanti, Ian J Saldanha, Ashrita Saran, Jochen Schmitt, Holger J Schünemann, Richard Sever, Mark Simmonds, Bhagteshwar Singh, Anneliese Synnot, Britta Tendal Jeppesen, James Thomas, David Tovey, Andrea Tricco, Tari Turner, Per Olav Vandvik, Helen Wakeford, Stephanie Weibel, Vivian Welch, Wojtek Wiercioch

Affiliations

¹ Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
² Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
³ Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.
⁴ Institute of Public Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁵ Immunization Unit, Department of Infectious Disease Epidemiology, Robert Koch-Institut, Berlin, Germany.
⁶ Infectious Disease Society of America, Arlington, VA, USA.
⁷ F1000 Research, London, UK.
⁸ Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

PMID: 39562017
PMCID: PMC12036629
DOI: 10.1136/bmj-2024-079183

Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation

Elie A Akl et al. BMJ. 2024.

. 2024 Nov 19:387:e079183.

doi: 10.1136/bmj-2024-079183.

Authors

Elie A Akl^{1

2}, Joanne Khabsa³, Claire Iannizzi⁴, Vanessa Piechotta⁵, Lara A Kahale⁶, James M Barker⁷, Joanne E McKenzie⁸, Matthew J Page⁸, Nicole Skoetz⁴; PRISMA-LSR Group

Collaborators

PRISMA-LSR Group:
Tony Aburrow, Sabina Alam, Lisa Askie, Vivienne C Bachelet, Asma Ben Brahem, Lex Bouter, Isabelle Boutron, Romina Brignardello-Petersen, Jacob Burns, Anna Chaimani, Christine Chang, Stephanie Chang, Mike Clarke, Tammy Clifford, Kerry Dwan, Julian Elliott, Robin Featherstone, Markus Follmann, Christian Gluud, Gordon Guyatt, Lotty Hooft, Anna Jacobs, Svenja Krebs, Tamara Kredo, Toby Lasserson, Elizabeth Loder, Helen Macdonald, Iain Marshall, Steve McDonald, Matthew Df McInnes, Joerg Meerpohl, Maria-Inti Metzendorf, David Moher, Lorenzo Moja, Karel Gm Moons, Mohammad Hassan Murad, Reem Mustafa, Stefano Negrini, Robby Nieuwlaat, Adriani Nikolakopoulou, Monika Nothacker, Rose O'Dea, Amir Qaseem, Gabriel Rada, Melissa L Rethlefsen, Ludovic Reveiz, Maria Ximena Rojas-Reyes, Jean-Paul Salameh, Georgia Salanti, Ian J Saldanha, Ashrita Saran, Jochen Schmitt, Holger J Schünemann, Richard Sever, Mark Simmonds, Bhagteshwar Singh, Anneliese Synnot, Britta Tendal Jeppesen, James Thomas, David Tovey, Andrea Tricco, Tari Turner, Per Olav Vandvik, Helen Wakeford, Stephanie Weibel, Vivian Welch, Wojtek Wiercioch

Affiliations

¹ Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
² Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
³ Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.
⁴ Institute of Public Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁵ Immunization Unit, Department of Infectious Disease Epidemiology, Robert Koch-Institut, Berlin, Germany.
⁶ Infectious Disease Society of America, Arlington, VA, USA.
⁷ F1000 Research, London, UK.
⁸ Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

PMID: 39562017
PMCID: PMC12036629
DOI: 10.1136/bmj-2024-079183

Abstract

Publications of living systematic reviews (LSRs) are increasing rapidly. Guidance facilitating transparent, complete, and accurate reporting of LSRs is needed. This paper reports the development of an extension of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 statement for LSRs (PRISMA-LSR). The PRISMA-LSR extension includes the PRISMA-LSR checklist, the PRISMA-LSR flow diagram, reporting recommendations for the LSR status, and an explanation and elaboration document. This extension has been developed as an “add-on” to the PRISMA 2020 statement, meaning it should be used in addition to the PRISMA 2020 statement. The PRISMA-LSR extension is expected to benefit authors, editors, peer reviewers, and users of LSRs through transparent, complete, and accurate reporting of LSRs.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years. NS has received consulting fees as senior editor at Cochrane Cancer (2021). JEM and MJP act as PRISMA executive co-chairs (2023 to current) and do not receive any payment for this role; they have also co-led the development of the PRISMA 2020 statement, but have no financial conflict of interest in relation to use of the guideline. Tamara Kredo is a Cochrane Board member. Views expressed are her own. Patient and public involvement: Although the authors attempted to recruit consumers to be part of this study, they were not successful in recruiting anyone.

Cited by

Interventions for the management of post-COVID-19 condition (long COVID): protocol for a living systematic review and network meta-analysis.
Zeraatkar D, Ling M, Kirsh S, Jassal T, Pitre T, Chakraborty S, Turner T, Turkstra L, McIntyre RS, Izcovich A, Mbuagbaw L, Agoritsas T, Flottorp SA, Garner P, Couban RJ, Busse JW. Zeraatkar D, et al. BMJ Open. 2025 Feb 7;15(2):e086407. doi: 10.1136/bmjopen-2024-086407. BMJ Open. 2025. PMID: 39920063 Free PMC article.
Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges.
Bas TG. Bas TG. Pharmaceuticals (Basel). 2025 Jun 17;18(6):908. doi: 10.3390/ph18060908. Pharmaceuticals (Basel). 2025. PMID: 40573303 Free PMC article. Review.
Cochrane's COVID-19 Living Systematic Reviews: A Mixed-Methods Study of Their Conduct, Reporting and Currency.
De Silva K, Turner T, McDonald S. De Silva K, et al. Cochrane Evid Synth Methods. 2025 Mar 28;3(3):e70024. doi: 10.1002/cesm.70024. eCollection 2025 May. Cochrane Evid Synth Methods. 2025. PMID: 40656451 Free PMC article.

References

1. Bendersky J, Auladell-Rispau A, Urrútia G, Rojas-Reyes MX. Methods for developing and reporting living evidence synthesis. J Clin Epidemiol 2022;152:89-100. 10.1016/j.jclinepi.2022.09.020 - DOI - PubMed
1. Breuer C, Meerpohl JJ, Siemens W. From standard systematic reviews to living systematic reviews. Z Evid Fortbild Qual Gesundhwes 2023;176:76-81. 10.1016/j.zefq.2022.11.007 - DOI - PubMed
1. Elliott JH, Turner T, Clavisi O, et al. . Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med 2014;11:e1001603. 10.1371/journal.pmed.1001603 - DOI - PMC - PubMed
1. Zheng Q, Xu J, Gao Y, et al. . Past, present and future of living systematic review: a bibliometrics analysis. BMJ Glob Health 2022;7:e009378. 10.1136/bmjgh-2022-009378 - DOI - PMC - PubMed
1. Elliott JH, Synnot A, Turner T, et al. Living Systematic Review Network . Living systematic review: 1. Introduction-the why, what, when, and how. J Clin Epidemiol 2017;91:23-30. 10.1016/j.jclinepi.2017.08.010 - DOI - PubMed

LinkOut - more resources

Full Text Sources

[1] Bendersky J, Auladell-Rispau A, Urrútia G, Rojas-Reyes MX. Methods for developing and reporting living evidence synthesis. J Clin Epidemiol 2022;152:89-100. 10.1016/j.jclinepi.2022.09.020 - DOI - PubMed

[2] Bendersky J, Auladell-Rispau A, Urrútia G, Rojas-Reyes MX. Methods for developing and reporting living evidence synthesis. J Clin Epidemiol 2022;152:89-100. 10.1016/j.jclinepi.2022.09.020 - DOI - PubMed

[3] Breuer C, Meerpohl JJ, Siemens W. From standard systematic reviews to living systematic reviews. Z Evid Fortbild Qual Gesundhwes 2023;176:76-81. 10.1016/j.zefq.2022.11.007 - DOI - PubMed

[4] Breuer C, Meerpohl JJ, Siemens W. From standard systematic reviews to living systematic reviews. Z Evid Fortbild Qual Gesundhwes 2023;176:76-81. 10.1016/j.zefq.2022.11.007 - DOI - PubMed

[5] Elliott JH, Turner T, Clavisi O, et al. . Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med 2014;11:e1001603. 10.1371/journal.pmed.1001603 - DOI - PMC - PubMed

[6] Elliott JH, Turner T, Clavisi O, et al. . Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med 2014;11:e1001603. 10.1371/journal.pmed.1001603 - DOI - PMC - PubMed

[7] Zheng Q, Xu J, Gao Y, et al. . Past, present and future of living systematic review: a bibliometrics analysis. BMJ Glob Health 2022;7:e009378. 10.1136/bmjgh-2022-009378 - DOI - PMC - PubMed

[8] Zheng Q, Xu J, Gao Y, et al. . Past, present and future of living systematic review: a bibliometrics analysis. BMJ Glob Health 2022;7:e009378. 10.1136/bmjgh-2022-009378 - DOI - PMC - PubMed

[9] Elliott JH, Synnot A, Turner T, et al. Living Systematic Review Network . Living systematic review: 1. Introduction-the why, what, when, and how. J Clin Epidemiol 2017;91:23-30. 10.1016/j.jclinepi.2017.08.010 - DOI - PubMed

[10] Elliott JH, Synnot A, Turner T, et al. Living Systematic Review Network . Living systematic review: 1. Introduction-the why, what, when, and how. J Clin Epidemiol 2017;91:23-30. 10.1016/j.jclinepi.2017.08.010 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation

Collaborators

Affiliations

Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation

Authors

Collaborators

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources